Advanced Biomed Inc. (ADVB)
NasdaqCM: ADVB
· Real-Time Price · USD
8.59
-0.13 (-1.49%)
At close: Aug 19, 2026, 3:45 PM
8.30
-0.60%
Pre-market: 4:44 AM
Advanced Biomed Inc. (ADVB) Stock Price, Analysis & Data
-1.49% (1D)
| Bid | 6.52 |
| Market Cap | 13.8M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 4.76M |
| Beta | n/a |
| EPS (ttm) | 3.93 |
| PE Ratio (ttm) | 2.12 |
| Forward PE | n/a |
| P/B (ttm) | 1.25 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 8.74 |
| Volume | 111,046 |
| Avg. Volume (20D) | 1,752,667 |
| Open | 8.39 |
| Previous Close | 8.72 |
| Day's Range | 8.39 - 9.41 |
| 52-Week Range | 3.61 - 24.23 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ADVB
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a c...
Industry Diagnostics & Research
Sector Healthcare
IPO Date Mar 6, 2025
Employees 31
Stock Exchange NasdaqCM
Ticker Symbol ADVB
Website https://www.advanbiomed.com
Financial Performance
In 2024, Advanced Biomed's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -2.78M, a decrease of -25.46%.
Financial Statements